At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Due to growth and launch activities, we are seeking an Executive Director in the International Business Unit (IBU) team to ensure a successful launch for Lilly’s developmental assets in Obesity and related Metabolic indications across IBU countries.

We are looking for you to be a member of the Lilly Diabetes IBU Medical team, being front and centre in the strategic planning in the support of launch and commercialisation activities to meet patients’ needs and ultimately enhance the customers’ experience in interacting with the company.

Responsibilities:

• Using your medical expertise in Obesity/Metabolic disorders across the Lilly Diabetes portfolio in the Incretin space.

• Leading clinical research activities related to the Incretin portfolio in Metabolic disorders across IBU regions.

• Partnering with relevant functions within Lilly teams also contributing to the development, review and approval of promotional materials for the brand team.

• Developing effective partnerships with clinicians, other key influencers and external groups and relevant medical societies.

• Supporting the Global teams with Local launch related processes including collaborating with other internal functions Medical Affairs, Medical Education, Marketing/Brand, business planning and the approval appropriate materials.

• Offering your scientific input, contribute to the development, review and approval of promotional materials for the brand team.

Provision of Medical Expertise

• Ensure detailed, up-to-date knowledge of the data surrounding the respective Molecule(s).

• Collborate with Global Regulatory team on strategy for the Incretin portfolio.

• Input into regulatory submissions and Health Technology Assessments (HTAs)

• Drive and take accountability for the process and content of scientific publications, using this to provide initial and ongoing disease, product and competitor training.

Clinical Planning/Clinical Research/Trial Execution and Support

• Input into the development of Global and Regional relevant Clinical Trial (CT) plans and strategy for Incretin portfolio.

• Implement, in consultation with the Clinical Operations lead, the Global / Regional CT plan with Quality, Speed and Value.

• Support for Investigator Initiated Trial process for the portfolio.

External Relations

• Identify and engage with Health Care Professionals (HCPs), Advocacy Groups, government and other professional bodies as determined by business needs.

• Share and involve relevant HCPs in new developments / data surrounding the product

• Drive appropriate involvement of relevant HCPs with publications and product communications.

Qualifications:

• Basic Medical Qualification (MBBS/MD) with a deep therapeutic area clinical expertise within Obesity and other related Metabolic diseases.

• Evidence of at least 3 years’ experience in relevant Drug Development and Medical Affairs activities in the Pharmaceutical industry or published academic research background in Obesity and Metabolic disorders.

• Demonstrate a track record of key contributions to scientific knowledge in the field of Obesity and related Metabolic disorders.

• Deep understanding and working relationships with key International Opinion Leaders and professional organisations in the field of Chronic Weight Management, Obesity and Metabolic disorders.

• Excellent communication skills (presentation, written and verbal) - Fluent in English.

• Demonstrated ability to plan, organise, prioritise and adapt to changing needs.

Embracing diversity is at the core of our long-held value of respect for people. It is the lens through which we understand and respond to the unique needs of the millions of individuals who depend on our medicines.

For us, embracing diversity means understanding, respecting, and valuing differences, including but not limited to race, colour, religion, sex, sexual orientation, gender identity, national origin, disability, or any other legally protected status. The greatest measure of our diversity efforts is our ability to attract and retain exceptional employees who feel comfortable in a culture that supports them being themselves. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.

#LI-MA1

Eli Lilly and Company, Lilly USA, LLC and our wholly owned subsidiaries (collectively “Lilly”) are committed to help individuals with disabilities to participate in the workforce and ensure equal opportunity to compete for jobs. If you require an accommodation to submit a resume for positions at Lilly, please email Lilly Human Resources ( Lilly_Recruiting_Compliance@lists.lilly.com ) for further assistance. Please note This email address is intended for use only to request an accommodation as part of the application process. Any other correspondence will not receive a response.

Lilly does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.

#WeAreLilly